Advertisement
IN Stocks

Hindustan Unilever Ltd Jumps 2.75% as JPMorgan Flags Premiumisation Growth

June 10, 2026
01:14 PM
3 min read

Key Points

Hindustan Unilever Ltd's premium portfolio grows 15–20% annually, outpacing its 3–5% base portfolio growth.

Q4 FY26 net profit rose 21.43% to ₹2,992 crore; revenue climbed 8.15% year-over-year.

Analyst consensus 12-month price target stands at ₹2,600; Morgan Stanley targets ₹2,480 per share.

HUL's ₹22 dividend ex-date is June 23; Q1 FY27 earnings report due July 16.

Be the first to rate this article

₹2,191.50. Up ₹58.70. In a single session. Hindustan Unilever Ltd (HINDUNILVR.NS) delivered one of its sharpest single-day moves in months on June 10, 2026, with the stock climbing 2.75% as fresh brokerage commentary on India’s premiumisation trend landed at exactly the right time. Hindustan Unilever Ltd gained for a fifth straight session.

Advertisement

The stock trading at ₹2,141.80 as of the June 9 intraday print with the Nifty FMCG index up 1.63% on the day. The June 10 move extends that streak. The stock’s 52-week range spans ₹2,022.50 to ₹2,697.48; today’s print signals a clear push away from the lower end of that range.

Why JPMorgan’s Premiumisation Call Matters Right Now

The timing of this note is deliberate. Hindustan Unilever Ltd’s management has been flagging premiumisation as its primary volume driver, and Wall Street is now validating that strategy.

  • HUL’s premium portfolio, including Dove, Lux Platinum, Surf Excel Matic, Vaseline Clinical Care, and Lakmé Absolute, is growing at 15-20% annually versus just 3–5% for the base portfolio.
  • As the premium mix expands, blended EBITDA margin expansion toward 25%+ is projected by FY27-28.
  • The consensus 12-month price target stands at ₹2,600 per share. Analysts calling HUL India’s highest-quality FMCG franchise trading at a discount to its 52-week high.
  • Morgan Stanley raised its Hindustan Unilever Ltd price target to ₹2,480 on May 4, 2026, maintaining an Equal-Weight rating, a sign that multiple global banks are converging on a constructive view.

Q4 FY26 Results Gave the Bulls Something to Work With

The Numbers That Preceded Today’s Move

The JPMorgan note did not emerge in a vacuum. Hindustan Unilever Ltd’s Q4 FY26 net profit rose 21.43% to ₹2,992 crore compared to ₹2,464 crore in Q4 FY25. Revenue from operations grew 8.15% to ₹16,207 crore versus ₹14,985 crore in the year-ago quarter.

Q3 FY26 gross margin hit 51.5%, up 130 basis points year-over-year, approaching the historical peak range of 53-54%. These numbers gave analysts the earnings foundation to make a credible premiumisation growth case.

Dividend, AGM, and Shareholder Calendar

Hindustan Unilever Ltd is not just an earnings story this month; it has a packed shareholder calendar that adds near-term visibility.

  • HUL announced a ₹22 per share cash dividend with an ex-date of June 23, 2026. 
  • The company’s 93rd Annual General Meeting is scheduled for June 30, 2026, where dividend approval and director reappointments will be on the agenda.
  • The next quarterly earnings report is due on July 16, 2026. This is the most important data point for testing whether the premiumisation thesis translates into Q1 FY27 numbers.
  • Promoter holding (Unilever PLC) stands firm at 61.9%, with total market capitalization at ₹5,01,673 crore.
Advertisement

Final Thoughts

Hindustan Unilever Ltd is at an inflection point. HUL has been range-bound between ₹2,100 and ₹2,780 for the better part of 18 months, but gross margin recovery, premium portfolio acceleration, and rural demand improvement are converging simultaneously. The JPMorgan note adds institutional conviction to a story the numbers are already telling.

July 16 earnings will be the definitive test of whether premiumisation growth has shifted from strategy to sustained delivery. Peer FMCG names Nestlé India (NSE: NESTLEIND), Dabur (NSE: DABUR), and ITC (NSE: ITC) will face the same scrutiny.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)